Dilated cardiomyopathy trials in United Kingdom
7 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
- Where
- Bristol, Cambridge, Glasgow, Leicester, London, Oxford
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Kardigan, Inc.
See details and how to joinNCT07210723 - Phase 3Taking peopleA Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
- Where
- Bristol, Glasgow, Leicester, London, Oxford
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Kardigan, Inc.
See details and how to joinNCT07771465 - Phase 1/2Taking peopleALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
- Where
- London
- Age
- 18 years to 70 years
- People
- 6 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07218887 · EU 2024-519674-40-00 - No phaseTaking peopleMayo AVC Registry and Biobank
- Where
- Papworth Everard
- People
- 1,000 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT03049254 - No phaseTaking peopleThe Heart Hive - Cardiomyopathy Study
- Where
- London
- Age
- 18 years and over
- People
- 10,000
- Run by
- Imperial College London
See details and how to joinNCT04612296 - Phase 2Not yet taking people in United KingdomRepurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age
- Where
- London
- Age
- 6 years to 18 years
- People
- 12
- Run by
- Sebastiano Lava
See details and how to joinNCT06643442 - No phaseTaking peopleThe SMARTER Cardiomyopathy Study
- Where
- London
- People
- 1,000
- Run by
- Imperial College London
See details and how to joinNCT05750147